Cogan syndrome with systemic manifestations
https://doi.org/10.51793/OS.2024.27.2.001
Abstract
Background. Cogan syndrome is a rare systemic vasculitis with variable arterial involvement. Its true prevalence is unknown. It is characterized by ocular symptoms, hearing loss, vestibular dysfunction. Cogan syndrome can be classified as typical or atypical. Typical syndrome is characterized by a combination of bilateral keratitis with hearing loss and vestibular dysfunction. Atypical syndrome includes other types of eye or hearing damage and cases when the interval separating these symptoms onset exceeds 2 years. Systemic manifestations are more common in atypical Cogan syndrome. There are different theories about the development of the disease. Currently, the most popular autoimmune theory is that Cogan syndrome is based on autoimmune vasculitis of the most vascularized layers of the eye, inner ear and other organs. The search for immune markers in Cogan syndrome led to the discovery of antibodies to antigens of the inner ear, cornea, and antiendothelial antibodies, but their diagnostic value is not great. Immune markers that allow a confident diagnosis have not yet been discovered.
Objective. Report a case of the Cogan syndrome with systemic manifestations in a female patient.
Results. We present the clinical case of Cogan syndrome in a 37-year-old patient. The disease was diagnosed based on the presence of acute conjunctivitis, acute bilateral sensorineural hearing loss, dizziness. These symptoms were preceded by fever, arthralgia, myalgia, diarrhea. Conjunctivitis and audiovestibular symptoms appeared at the same time. Additionally, the patient exhibited systemic manifestations such as polyserositis, pneumonitis, erosive colitis with malabsorption syndrome, abdominal lymphadenopathy, anemia, thrombocytopenia. The notable aspect of the case was a very early diagnosis (a week after the onset of the disease). This factor determined the achievement of a good and rapid response to treatment within the first week. Treatment included glucocorticoids, pulse cyclophosphamide therapy. Within a month, all symptoms were completely resolved.
Conclusion. Early diagnosis and timely treatment of Cogan syndrome makes it possible to completely relieve symptoms of the syndrome and prevent deafness.
About the Authors
Nataliya А. MorovaРоссия
Nataliya A. Morova, Dr. of Sci. (Med.), Professor, Head of the Department of Hospital Therapy, Endocrinology,
12, Lenin Street, Omsk, 644099.
Yulia V. Arbuzova
Россия
Yulia V. Arbuzova, Head of the Department of Rheumatology
3, Berezovaya str., Omsk, 644111.
References
1. Cogan D. G. Syndrome of nonsyphilitic interstitial keratitis and vestibulo-auditory symptoms. Archives of Ophthalmology. 1945; 33: 144-149.
2. Morgan R., Baumgartner C. J. Meniers disease complicated by recurrent interstitial keratitis: excellent results following cervical ganglionectomy. West Journal Surgery. 1934; 42: 628-631.
3. Haynes B. F., Kaiser-Kupfer M. I., Mason P., Fauci A. S. Cogan syndrome: studies on thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore). 1980; 59 (6): 426-441.
4. Massinger C., Keilmann A. Cogan-I-syndrome a rare differential diagnosis in progressive sensorineural hearing loss. HNO. 2003; 51 (1): 66-70. DOI: 10.1007/s00106-002-0707-8.
5. Beketova T. V. Cogan's syndrome is a new nosological entity in the current classification of systemic vasculitis: A clinical case and a review of literature. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016; 54 (4): 463-468. (In Russ.) DOI: http://dx.doi.org/10.14412/1995-4484-2016-463-468.
6. Espinoza G., Prost A. Cogan's syndrome and other ocular vasculitides. Curr Rheumatol Rep. 2015; 17 (4): 24.
7. Kessel A., Vadasz Z., Toubi E. Cogan syndrome-pathogenesis, clinical variants and treatment approaches. Autoimmunity Reviers. 2014; 13 (4-5): 351-354.
8. Espinoza G., Wheeler J., Temprano K., Keller A. P. Cogan’s Syndrome: Clinical Presentations and Update on Treatment. Current Allergy and Asthma Reports. 2020; 9 (20). DOI: 10.1007/s11882-020-00945-1.
9. Gluth M. B., Baratz K. H., Matteson E. L., Driscoll C. L. А Retrospective Review of 60 Patients throughout a Half Century. Mayo Clin Proc. 2006; 81 (4): 483-488.
10. Seelarbokus M. A., Kelly C. Cogan's syndrome – a neglected autoimmune vasculitis. Rheumatology Advances in Practice. 2021; 5 (1): rkab068.030. doi.org/10.1093/rap/rkab068.030.
11. Sevgi D. D., Sobrin L., Papaliodis G. N. Cogan syndrome with severe medium and large vessel vasculitis. Digit J Ophthalmol. 2016; 22 (1): 32-34. DOI: 10.5693/djo.02.2015.09.002.
12. Mohseni M. M. Acute Limb Ischemia in Cogan Syndrome. Am J Case Rep. 2022; 23: e935929. DOI: 10.12659/AJCR.935929.
13. Espinoza G., Prost A. Cogan’s syndrome and other ocular vasculitides. Curr Rheumatol Rep. 2015; 17 (4): 24. https://doi.org/10.1007/s11926-015-0499-y.
14. Morova N. A., Kropotina T. V., Arbuzova Yu. V. Cogan's syndrome: Success of immunosuppressive therapy. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016; 54 (5): 598-600. (In Russ.) DOI: http://dx.doi.org/10.14412/1995-4484-2016-598-600.
15. Durtette C., Éric H., Resche-Rigon M., et al. Cogan syndrome: Characteristics, outcome and treatment in a French nationwide retrospective study and literature review. Autoimmunity Reviews. 2017; 16 (12): 1219-1223. https://doi.org/10.1016/j.autrev.2017.10.005.
16. Wang Y., Tang S., Shao C., Liu Y. Cogan's syndrome is more than just keratitis: a case-based literature review. Ophthalmol. 2023; 23 (1): 212. DOI: 10.1186/s12886-023-02966-6.
17. Tirelli G., Tomietto P., Quatela E., et al. Sudden hearing loss and Crohn disease: when Cogan syndrome must be suspected. American Journal of Otolaryngology. 2015; 36 (4): 590-597. DOI: 10.1016/j.amjoto.2015.02.013.
Review
For citations:
Morova N.А., Arbuzova Yu.V. Cogan syndrome with systemic manifestations. Lechaschi Vrach. 2024;(2):7-11. (In Russ.) https://doi.org/10.51793/OS.2024.27.2.001
JATS XML



















